Not registered yet? Get a free account.

Sign Up
search icon cancel icon

ALNES PHARMA INDIA PRIVATE LIMITED

Active
Updated: 28 Dec 2022

Alnes Pharma India Private Limited, is an unlisted private company incorporated on 24 February, 2021. It is classified as a private limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 10.00 lac and the total paid-up capital is INR 5.00 lac.

The current status of Alnes Pharma India Private Limited is - Active.

Read more

Industry and products
Manufacturing (Machinery & Equipments)
Company size
Auth Capital
₹ 10.0 L
Paidup Capital
₹ 5.0 L
Revenue
Not Available
Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Total Revenue
8.9%
₹ GET PRO
EBITDA
7.69%
₹ GET PRO
Net Profit
-68.97%
₹ GET PRO
Networth
2.15%
₹ GET PRO
Borrowings
6.23%
₹ GET PRO
Assets
5.07%
₹ GET PRO
Gross Margin
5.57
GET PRO %
Operating Margin
-0.31
GET PRO %
Net Profit Margin
-8.37
GET PRO %
Return on Equity
-8.01
GET PRO %
ROCE
-0.76
GET PRO %
Debt to Equity
0.01
GET PRO
Sales
Mar 2024
Net worth
Mar 2024

Locations

indian flag India (1)
State Type Address

location icon Locations on Map

Map placeholder

People

Designation Name DIN/PAN Tenure
Director Suresha Eranna 08065596 4 years
Director Negalaguli Aravinda 09079618 4 years
Director Ademane Prabhavati 09079619 4 years

Financial Highlights

** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

Bank wise
Charges
1

Punjab National Bank

No. of Loans: 1

Total Amount : 0.1 cr

chart icon

Charges

Punjab National Bank

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
AMRUTHA DIAGNOSTIC CENTRE INDIA PRIVATE LIMITED
Active
1.0 L 1 Karnataka

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U33100KA2021PTC144543

PAN

-

Incorporation

2021, 4.2 years

Company Email

ALNESPHARMAINDIA@GMAIL.COM

Paid up Capital

₹ 5.0 L

Authorised Capital

₹ 10.0 L

AGM

Sep 2022

Type

Private
Non-government Company

FAQ - ALNES PHARMA INDIA PRIVATE LIMITED

What is the incorporation date of ALNES PHARMA INDIA PRIVATE LIMITED?

plus icon

The incorporation date of ALNES PHARMA INDIA PRIVATE LIMITED is 24 February, 2021

What is the authorized share capital of ALNES PHARMA INDIA PRIVATE LIMITED?

plus icon

The authorized share capital of ALNES PHARMA INDIA PRIVATE LIMITED is INR ₹ 10.0 L.

What is the paid-up capital of ALNES PHARMA INDIA PRIVATE LIMITED?

plus icon

The paid-up capital of ALNES PHARMA INDIA PRIVATE LIMITED is INR ₹ 5.0 L.

What is the registered address of ALNES PHARMA INDIA PRIVATE LIMITED?

plus icon

The registered address of ALNES PHARMA INDIA PRIVATE LIMITED is No. 287, Ground Floor, MIG 15th A Cross, Chikkabommasandra, Yelahanka New Town Bangalore Bangalore Karnataka - 560064

What is the CIN number of ALNES PHARMA INDIA PRIVATE LIMITED?

plus icon

The CIN number of ALNES PHARMA INDIA PRIVATE LIMITED is U33100KA2021PTC144543.

Smart Suggestions

  • Assam
  • Odisha
  • West Bengal
  • Chhattisgarh
  • Rajasthan
  • Himachal Pradesh
  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More